2,345 Shares in Agilent Technologies, Inc. $A Bought by Sagespring Wealth Partners LLC

Key Points

• Sagespring Wealth Partners LLC acquired 2,345 shares of Agilent Technologies during the second quarter, valued at approximately $277,000.
• Agilent Technologies reported quarterly earnings of $1.37 EPS, meeting consensus estimates, alongside a 10.1% increase in revenue year-over-year.
• The company declared a quarterly dividend of $0.248, with an annualized dividend yield of 0.7%, set to be paid on October 22nd.

Sagespring Wealth Partners LLC bought a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 2,345 shares of the medical research company's stock, valued at approximately $277,000.

A number of other large investors have also added to or reduced their stakes in the company. Stone House Investment Management LLC purchased a new position in shares of Agilent Technologies in the 1st quarter worth approximately $30,000. Ransom Advisory Ltd acquired a new stake in Agilent Technologies in the first quarter valued at approximately $32,000. Central Pacific Bank Trust Division acquired a new stake in Agilent Technologies in the second quarter valued at approximately $33,000. Zions Bancorporation National Association UT purchased a new position in Agilent Technologies in the first quarter worth $38,000. Finally, Costello Asset Management INC purchased a new stake in shares of Agilent Technologies during the 1st quarter valued at $47,000.

Agilent Technologies Price Performance

Shares of NYSE A opened at $142.01 on Friday. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84. The business's 50 day moving average price is $127.58 and its 200 day moving average price is $117.83. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The firm has a market cap of $40.26 billion, a P/E ratio of 33.34, a P/E/G ratio of 4.61 and a beta of 1.26.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, meeting the consensus estimate of $1.37. The business had revenue of $1.74 billion during the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business's quarterly revenue was up 10.1% compared to the same quarter last year. During the same period in the previous year, the business posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be paid a $0.248 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies's dividend payout ratio is presently 23.24%.

Analyst Ratings Changes

Several research analysts recently issued reports on the company. Rothschild & Co Redburn assumed coverage on Agilent Technologies in a research report on Wednesday, October 8th. They set a "buy" rating and a $165.00 target price on the stock. Robert W. Baird upped their price objective on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an "outperform" rating in a report on Thursday, August 28th. JPMorgan Chase & Co. lifted their target price on shares of Agilent Technologies from $155.00 to $165.00 and gave the stock an "overweight" rating in a research note on Thursday, October 9th. Weiss Ratings restated a "hold (c)" rating on shares of Agilent Technologies in a research note on Wednesday, October 8th. Finally, TD Cowen raised their price target on shares of Agilent Technologies from $150.00 to $162.00 and gave the stock a "buy" rating in a report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $149.62.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.